`
`lnventor:
`
`RAJIV R. SINGH ET AL.
`
`Examiner: A.S. KHAN
`
`Application No.: 13/844,206
`
`Conf. No.: 2285
`
`Group Art Unit: 1761
`
`Filed:
`
`MARCH 15, 2013
`
`Docket No.: H0003965DlV1C
`
`Title: HEAT TRANSFER COMPOSITIONS AND METHODS
`
`FILED ELECTRONICALLY ON NOVEMBER 5, 2014
`
`Commissioner for Patents
`
`P. O. Box 1450
`
`Alexandria, VA 22313-1450
`
`RESPONSE TO NOTICE OF NONCOMPLIANT AMENDMENT
`
`Madam:
`
`This is in response to the Notice OF Non-Compliant Amendment dated
`
`September 5, 2014. Applicants believe that no additional fees are currently due in
`
`connection with this communication or to further the prosecution of this application.
`
`However, if any fees are necessary, please charge such fees to Deposit Account No.
`
`50-1943.
`
`Amendments to the claims begin on page 2.
`
`Remarks begin on page 7.
`
`ACTIVE 28017444V1
`
`1 Of 7
`
`Arkema Exhibit 1085
`
`Arkema Exhibit 1085
`
`1 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`Amendment to the Claims
`
`This listing of claims replaces all prior versions and listings of claims in the application.
`
`Listing of the Claims
`
`1. (Withdrawn) A method of depositing catalyst on a solid support comprising
`
`precipitating particles of said catalyst from a compound of formula I in a supercritical or
`
`near supercritical state:
`
`XCFzR3_z (I)
`
`where X is a C2 or a C3 unsaturated, substituted or unsubstituted, radical, R is
`
`independently Cl, F, Br,
`
`I or H, and z is 1 to 3.
`
`2. (Withdrawn) The method of claim 1 wherein Y is CF3.
`
`3. (Withdrawn) The method of claim 2 wherein at least one R on the unsaturated
`
`terminal carbon is H.
`
`4. (Withdrawn) The method of claim 3 wherein n is 0.
`
`5. (Withdrawn) The method of claim 1 wherein n is O.
`
`6. (Withdrawn) The method of claim 1 wherein Y is CF3 and n is O.
`
`7. (Withdrawn) The method of claim 1 wherein said at least one fluoroalkene comprises
`
`at least one tetrafluoropropene (HFO-1234).
`
`8. (Withdrawn) The method of claim 7 wherein said at least one fluoroalkene further
`
`comprises at least one pentafluoropropene (HFO-1225).
`
`20f7
`
`2 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`9. (Withdrawn) The method of claim 7 wherein said at least one tetrafluoropropene
`
`comprises 1,3,3,3—tetrafluoropropene (HFO-1234ze).
`
`10. (Withdrawn) A cleaning composition comprising at least one fluoroalkene of
`
`Formula I:
`
`XCFzR3—z (l)
`
`where X is a C2 or a C3 unsaturated, substituted or unsubstituted, alkyl radical, R is
`
`independently Cl, F, Br,
`
`I or H, and z is 1 to 3.
`
`11. (Withdrawn) The cleaning composition of claim 10 having a Global Warming
`
`Potential (GWP) of not greater than about 1000.
`
`12. (Withdrawn) The cleaning composition of claim 10 in the form of an aerosol.
`
`13. (Currently Amended) A method of applying a medicament or other therapeutic
`
`component to an organism comprising:
`
`(a)_providing a composition comprising the medicament or other therapeutic component
`
`and at least one fluoroalkene having at least four halogen substituents and being in
`
`accordance with Formula u l—:
`
`
`
`,-/nu
`
`"-r,.',:F"
`
`where R’ is CF{;)flfi§,
`
`nis0or1 and
`
`30f7
`
`3 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`each R is independently H, Cl or F, provided at least one R on the unsaturated
`
`terminal carbon is H; and
`
`(Q) introducing said composition to the organism.
`
`14. (Original) The method of claim 13 wherein said organism is a human.
`
`15. (Original) The method of claim 13 wherein said introducing step comprises
`
`providing said composition to a metered dose inhaler (MDI) and discharging the
`
`composition from said MDI.
`
`16. (Withdrawn) A method of sterilizing an article comprising contacting said article with
`
`a composition comprising at least one fluoroalkene in accordance with Formula I:
`
`XCFzR3—z (l)
`
`where X is a C2 or a C3 unsaturated, substituted or unsubstituted, alkyl radical, R is
`
`independently Cl, F, Br,
`
`I or H, and z is 1 to 3.
`
`17. — 20. (Canceled)
`
`e
`
`5
`
`_15¥. (New) The method of claim 13 wherein said at least one fluoroalkene in
`
`accordance with Formula II comprises one or more tetrafluoropropenes.
`
`Q58. (New) The method of claim 13 wherein said at least one fluoroalkene in
`
`accordance with Formula II comprises trans-1, 3, 3, 3-tetrafluoropropene (transHFO—
`
`1234ze)
`
`$59. (New) The method of claim £58 wherein said transHFO—1234ze is present in
`
`the composition in an amount of from about 5% by weight to about 99% by weight.
`
`40f7
`
`4 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`Q69. (New) The method of claim Q58 wherein said transHFO—1234ze is present in
`
`the composition in an amount of from about 5% by weight to about 95% by weight.
`
`Q61. (New) The method of claim gee wherein said at least one fluoroalkene in
`
`accordance with Formula II consists essentially of transHFO-1234ze.
`
`@612. (New) The method of claim 13 wherein said at least one fluoroalkene in
`
`accordance with Formula II consists essentially of one or more tetrafluoropropenes.
`
`Q63. (New) The method of claim géfir wherein said organism is a human.
`
`$64. (New) The method of claim 13 wherein said composition consists essentially of
`
`said medicament and/or other therapeutic component and said at least one
`
`fluoroalkene.
`
`Q65. (New) The method of claim Q64 wherein said at least one fluoroalkene in
`
`accordance with Formula II consists essentially of one or more tetrafluoropropenes
`
`$66. (New) The method of claim £64 wherein said at least one fluoroalkene in
`
`accordance with Formula II consists essentially of transHFO-1234ze.
`
`$61. (New) The method of claim 14 wherein said introducing step comprises providing
`
`said composition to a metered dose inhaler (MDI) and discharging the composition from
`
`said MDI.
`
`Q68. (New) The method of claim Q63 wherein said introducing step comprises
`
`providing said composition to a metered dose inhaler (MDI) and discharging the
`
`composition from said MDI.
`
`50f7
`
`5 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`$69. (New) The method of claim Q66 wherein said introducing step comprises
`
`providing said composition to a metered dose inhaler (MDI) and discharging the
`
`composition from said MDI.
`
`3419. (New) The method of claim $69 wherein said organism is a human.
`
`56. Canceled.
`
`60f7
`
`6 of 7
`
`
`
`Attorney Docket No. H0003965DIV1C
`
`REMARKS
`
`Reconsideration of the present application in view of the above amendments and
`
`the following remarks is respectfully requested.
`
`A complete listing of all of the claims is now present in ascending numerical
`
`order.
`
`Applicants believe that the above amendments and remarks place the present
`
`application in condition for allowance and an early notice thereof is earnestly solicited.
`
`Dated: November 5, 2014
`
`Respectfully submitted,
`
`/Joseph F. Posillico/
`Joseph F. Posillico
`Reg. No. 32,290
`FOX ROTHSCHILD LLP
`2000 Market Street, 20"‘ Fl.
`Philadelphia, PA 19103
`Telephone: 215-299-2902
`Facsimile: 215-299-2510
`
`70f7
`
`7 of 7